COLL Collegium Pharmaceutical, Inc.

$22.75▼ -0.74% Healthcare Other
After hours $22.80▲ +0.22% Sep 11, 7:30 PM ET
Volume 654.9K Avg Volume (10D) 980.0K
Key Metrics & Fundamentals
Market Cap
$705.23M
P/E Ratio
17.9
Div Yield
–%
52W Range
22.64 - 50.79
% vs 50 MA
-26.15%
% vs 200 MA
-39.53%
RSI-14
22.2
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.37
Free Cash Flow
$70.83M
Gross Rev
$199.88M
Gross Profit
$110.29M
EBITDA
$70.75M
COGS
$89.59M
Operating Exp
$106.59M
Operating Income
$3.70M
EBIT
$3.70M
Pretax Income
-$13.53M
Net Income
-$15.05M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target
MT Newswires · Sep 9, 2026 11:53 AM
Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating
MT Newswires · Sep 9, 2026 11:27 AM
Collegium to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 8, 2026 12:00 PM
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call
StockStory · Aug 15, 2026 11:25 AM
Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement
MT Newswires · Aug 13, 2026 1:19 PM
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 12:29 PM
Collegium Announces $50 Million Accelerated Share Repurchase Program
GlobeNewswire · Aug 13, 2026 11:30 AM
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance
StockStory · Aug 10, 2026 1:49 AM
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 3:27 AM
Collegium Pharmaceutical Inc (COLL) (Q2 2026) Earnings Call Highlights: ADHD Portfolio Surges ...
GuruFocus.com · Aug 6, 2026 7:03 PM
Financial Overview - Income Statement Quarterly

See COLL's money flow as a full page

Social Sentiment
Avg +0.90 · 1 posts
DDPriceTargetMakes a fortune in cash. Costs almost nothing to run. Protected by patents until 2037. COLL at $35 looks too cheap.
r/stocks · Jul 2, 2026
Strong bullish sentiment due to valuation metrics (70% margin of safety), revenue growth, and gross margins.
very_positive +0.90
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙